证券代码：688613 证券简称：奥精医疗 公告编号：2025-055

Summary of Key Points Core Viewpoint - BioVeda China RMB Investment Limited plans to reduce its stake in Aojing Medical Technology Co., Ltd. by up to 1,355,515 shares, representing 1% of the total shares before the implementation of the reduction plan [1][2]. Group 1: Shareholder Information - Before the reduction plan, BioVeda held 7,239,358 shares, accounting for 5.28% of Aojing Medical's total shares [1]. Group 2: Implementation Results - The reduction plan has been completed as per the disclosed schedule [2][3]. - The actual reduction has met the minimum reduction quantity as outlined in the initial plan [3].